111 related articles for article (PubMed ID: 10088833)
1. Pressure or progression?
Burnstein Y; Robin AL
Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
[No Abstract] [Full Text] [Related]
2. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
3. Systemic beta-blocker therapy and brimonidine and timolol.
Coulibaly R
Ophthalmology; 2001 Aug; 108(8):1368. PubMed ID: 11470677
[No Abstract] [Full Text] [Related]
4. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
Razeghinejad MR; Sawchyn AK; Katz LJ
Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
[TBL] [Abstract][Full Text] [Related]
5. [A long-term study of the visual fields in patients treated with betaxolol and timolol].
Flammer J; Collignon-Brach J; Demailly P; Graves SA
Oftalmologia; 1998; 42(1):77-82; discussion 82-3. PubMed ID: 9713206
[No Abstract] [Full Text] [Related]
6. Normal-tension glaucoma.
Anderson DR; Feuer W; Schiffman J
Ophthalmology; 2008 Mar; 115(3):590-1; author reply 591-2. PubMed ID: 18319115
[No Abstract] [Full Text] [Related]
7. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
8. [Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].
Titouamane S; Baudouin C
J Fr Ophtalmol; 2002 Jun; 25(6):568-75. PubMed ID: 12223942
[TBL] [Abstract][Full Text] [Related]
9. Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
Spaeth GL; Bernstein P; Caprioli J; Schiffman RM
Am J Ophthalmol; 2011 Jan; 151(1):93-99.e4. PubMed ID: 21111399
[TBL] [Abstract][Full Text] [Related]
10. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
12. Brimonidine (Alphagan): a clinical profile four years after launch.
David R
Eur J Ophthalmol; 2001; 11 Suppl 2():S72-7. PubMed ID: 11592536
[TBL] [Abstract][Full Text] [Related]
13. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
Greenfield DS; Liebmann JM; Ritch R; Krupin T;
Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
[TBL] [Abstract][Full Text] [Related]
14. Special considerations in low-tension glaucoma.
Krupin T
Can J Ophthalmol; 2007 Jun; 42(3):414-7. PubMed ID: 17508037
[TBL] [Abstract][Full Text] [Related]
15. Brimonidine--an alpha 2-agonist for glaucoma.
Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727
[No Abstract] [Full Text] [Related]
16. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
[TBL] [Abstract][Full Text] [Related]
17. The rate of progression and ocular perfusion pressure in the Low-pressure Glaucoma Treatment Study.
Quaranta L; Floriani I
Am J Ophthalmol; 2011 Nov; 152(5):880; author reply 880-1. PubMed ID: 22017846
[No Abstract] [Full Text] [Related]
18. [Alpha-2 adrenergic agonists in the treatment of glaucoma].
Apătăchioae I; Chiseliţă D
Oftalmologia; 1999; 47(2):35-40. PubMed ID: 10641099
[TBL] [Abstract][Full Text] [Related]
19. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term safety of glaucoma drugs.
Schuman JS
Expert Opin Drug Saf; 2002 Jul; 1(2):181-94. PubMed ID: 12904152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
